Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
J Clin Invest. 2019 Mar 1;129(3):1359-1371. doi: 10.1172/JCI124466. Epub 2019 Feb 18.
J Clin Invest. 2019.
PMID: 30645203
Free PMC article.
Clinical Trial.